National Center for Complementary & Integrative Health; Notice of Closed Meeting, 12621-12622 [2017-04176]

Download as PDF 12621 Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices CTSU AND NCI CIRB FORMS AND CTSU, CIRB AND CTEP SURVEYS—ESTIMATED ANNUALIZED BURDEN HOURS— Continued Average burden per response (in hours) Number of responses per respondent Form name Type of respondent Reviewer Worksheet Expedited Study Closure Review (Attachment B36). Reviewer Worksheet Expedited Review of Study Chair Response to CIRB-Required Modifications (Attachment B37). Reviewer Worksheet of Expedited IR (Attachment B38). Reviewer Worksheet—CPC—Determination of UP or SCN (Attachment B39). Annual Signatory Institution Worksheet About Local Context (Attachment B40). Annual Principal Investigator Worksheet About Local Context (Attachment B41). Study-Specific Worksheet About Local Context (Attachment B42). Study Closure or Transfer of Study Review Responsibility Form (Attachment B43). UP or SCN Reporting Form (Attachment B44). Change of SI PI Form (Attachment B45) ..... CTSU Website Customer Satisfaction Survey (Attachment C1). CTSU Help Desk Customer Satisfaction Survey (Attachment C2). CTSU OPEN Survey (Attachment C3) ......... CIRB Customer Satisfaction Survey (Attachment C4) Satisfaction Survey (Attachment C4). Follow-up Survey (Communication Audit) (Attachment C5). Website Focus Groups, Communication Project (Attachment C6 A–D). CIRB Board Member Annual Assessment Survey (Attachment C7). PIO Customer Satisfaction Survey (Attachment C8). Concept Clinical Trial Survey (Attachment C9). Prospective Clinical Trial Survey (Attachment C10). Low Accrual Clinical Trial Survey (Attachment C11). ETCTN PI Survey (Attachment 12) .............. ETCTN RS Survey (Attachment 13) ............ Board Members .................... 20 1 15/60 5 Board Members .................... 5 1 30/60 3 Board Members .................... 5 1 30/60 3 Board Members .................... 40 1 15/60 10 Health Care Practitioner ....... 400 1 40/60 267 Health Care Practitioner ....... 1800 1 20/60 600 Health Care Practitioner ....... 4800 1 20/60 1600 Health Care Practitioner ....... 1680 1 15/60 420 Health Care Practitioner ....... 360 1 20/60 120 Health Care Practitioner ....... Health Care Practitioner ....... 120 275 1 1 15/60 15/60 30 69 Health Care Practitioner ....... 325 1 15/60 81 Health Care Practitioner ....... Participants ........................... 60 600 1 1 15/60 15/60 15 150 Participants/Board Members 300 1 15/60 75 Participants/Board Members 18 1 1 18 Board Members .................... 60 1 20/60 20 Health Care Practitioner ....... 60 1 5/60 5 Health Care Practitioner ....... 500 1 5/60 42 Health Care Practitioner ....... 1000 1 1/60 17 Health Care Practitioner ....... 1000 1 1/60 17 Physician .............................. Health Care Practitioner ....... 75 175 1 1 15/60 15/60 19 44 Totals ..................................................... ............................................... 24,100 100,337 ........................ 15,525 Dated: February 15, 2017. Karla Bailey, PRA OMB Liaison, Office of Management Policy and Compliance, National Cancer Institute (NCI) National Institutes of Health (NIH). Number of respondents National Center for Complementary & Integrative Health; Notice of Closed Meeting the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and [FR Doc. 2017–04253 Filed 3–3–17; 8:45 am] Name of Committee: National Center for Complementary and Integrative Health Special Emphasis Panel, Exploratory Clinical Trials and Studies of Natural Products. Date: March 30, 2017. Time: 12:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4140–01–P asabaliauskas on DSK3SPTVN1PROD with NOTICES Total annual burden hours VerDate Sep<11>2014 19:24 Mar 03, 2017 Jkt 241001 PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 E:\FR\FM\06MRN1.SGM 06MRN1 12622 Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Yisong Wang, Ph.D., Scientific Review Officer, NCCIH/NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20817, 301–480–9483, yisong.wang@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Integrative Health, National Institutes of Health, HHS) Dated: February 28, 2017. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–04176 Filed 3–3–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings asabaliauskas on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications/ contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications/ contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Quantitative Imaging for Evaluation of Cancer Therapies (U01). Date: March 29, 2017. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W260, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W260, Bethesda, MD 20892– 9750, 240–276–5856, nadeem.khan@nih.gov. CBPL No. 27–01 27–05 27–06 27–07 Dated: February 28, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. D D D D 287 4928 473 4807 19:24 Mar 03, 2017 Notice of accreditation and approval of Inspectorate America Corporation as a commercial gauger and laboratory. ACTION: Notice is hereby given, pursuant to CBP regulations, that Inspectorate America Corporation has been approved to gauge petroleum and certain petroleum products and accredited to test petroleum and certain petroleum products for customs purposes for the next three years as of July 21, 2016. DATES: The accreditation and approval of Inspectorate America Corporation as commercial gauger and laboratory became effective on July 21, 2016. The next triennial inspection date will be scheduled for July 2019. FOR FURTHER INFORMATION CONTACT: Approved Gauger and Accredited Laboratories Manager, Laboratories and Scientific Services Directorate, U.S. Customs and Border Protection, 1300 Pennsylvania Avenue NW., Suite 1500N, Washington, DC 20229, tel. 202– 344–1060. SUPPLEMENTARY INFORMATION: Notice is hereby given pursuant to 19 CFR 151.12 and 19 CFR 151.13, that Inspectorate America Corporation, 22934 Lockness Ave, Torrance, CA 90501 has been approved to gauge petroleum and certain petroleum products and accredited to test petroleum and certain petroleum products for customs purposes, in accordance with the provisions of 19 CFR 151.12 and 19 CFR 151.13. Inspectorate America Corporation is approved for the following gauging procedures for petroleum and certain petroleum products from the American Petroleum Institute (API): SUMMARY: BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Accreditation and Approval of Inspectorate America Corporation, as a Commercial Gauger and Laboratory U.S. Customs and Border Protection, Department of Homeland Security. AGENCY: API chapters Title 3 ....................... 7 ....................... 8 ....................... 12 ..................... 17 ..................... [FR Doc. 2017–04173 Filed 3–3–17; 8:45 am] ASTM .............. .............. .............. .............. VerDate Sep<11>2014 Name of Committee: National Cancer Institute Special Emphasis Panel, Digital Platforms to Support Informal Cancer Caregiving. Date: March 30–31, 2017. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 4W032/34, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Scott A. Chen, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W526, Bethesda, MD 20892–9750, 240–276–6038, chensc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Cancer Biomarkers and Biospecimens. Date: March 31, 2017. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W106, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Reed A. Graves, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W106, Rockville, MD 20892– 9750, 240–276–6384, gravesr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Tank Gauging. Temperature Determination. Sampling. Calculations. Marine Measurement. Inspectorate America Corporation is accredited for the following laboratory analysis procedures and methods for petroleum and certain petroleum products set forth by the U.S. Customs and Border Protection Laboratory Methods (CBPL) and American Society for Testing and Materials (ASTM): Title Standard Standard Standard Standard Test Test Test Test Jkt 241001 Method Method Method Method PO 00000 for for for for API Gravity of Crude Petroleum and Petroleum Products (Hydrometer Method). Water in Crude Oils by Coulometric Karl Fischer Titration. Sediment in Crude Oils and Fuel Oils by the Extraction Method. Sediment in Crude Oil by Membrane Filtration. Frm 00090 Fmt 4703 Sfmt 4703 E:\FR\FM\06MRN1.SGM 06MRN1

Agencies

[Federal Register Volume 82, Number 42 (Monday, March 6, 2017)]
[Notices]
[Pages 12621-12622]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04176]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Integrative Health; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Integrative Health Special Emphasis Panel, Exploratory Clinical 
Trials and Studies of Natural Products.
    Date: March 30, 2017.
    Time: 12:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy

[[Page 12622]]

Boulevard, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Yisong Wang, Ph.D., Scientific Review Officer, 
NCCIH/NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20817, 301-
480-9483, yisong.wang@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.213, 
Research and Training in Complementary and Integrative Health, 
National Institutes of Health, HHS)

    Dated: February 28, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04176 Filed 3-3-17; 8:45 am]
 BILLING CODE 4140-01-P